GSE SYSTEMS INC, 10-Q filed on 16 Aug 23
v3.23.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2023
Jul. 31, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Document Transition Report false  
Entity File Number 001-14785  
Entity Registrant Name GSE Systems, Inc.  
Entity Central Index Key 0000944480  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 52-1868008  
Entity Address, Address Line One 6940 Columbia Gateway Dr.  
Entity Address, Address Line Two Suite 470  
Entity Address, City or Town Columbia  
Entity Address, State or Province MD  
Entity Address, Postal Zip Code 21046  
City Area Code 410  
Local Phone Number 970-7800  
Title of 12(b) Security Common Stock, $0.01 Par Value  
Trading Symbol GVP  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   24,802,296
v3.23.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,775 $ 2,789
Restricted cash, current 500 1,052
Contract receivables, net of allowance for credit loss 10,190 10,064
Prepaid expenses and other current assets 830 2,165
Total current assets 13,295 16,070
Equipment, software and leasehold improvements, net 682 772
Software development costs, net 646 574
Goodwill 6,299 6,299
Intangible assets, net 1,395 1,687
Restricted cash - long term 1,080 535
Operating lease right-of-use assets, net 609 506
Other assets 42 53
Total assets 24,048 26,496
Current liabilities:    
Current portion of long-term note 851 3,038
Accounts payable 1,719 1,262
Accrued expenses 2,490 2,084
Accrued compensation 1,842 1,071
Billings in excess of revenue earned 3,157 4,163
Accrued warranty 276 370
Income taxes payable 1,731 1,774
Derivative liabilities 1,718 603
Other current liabilities 483 1,286
Total current liabilities 14,267 15,651
Long-term note, less current portion 1,670 310
Operating lease liabilities noncurrent 358 160
Other noncurrent liabilities 214 144
Total liabilities 16,509 16,265
Commitments and contingencies (Note 16)
Stockholders' equity:    
Preferred stock $0.01 par value; 2,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock $0.01 par value; 60,000,000 shares authorized, 26,401,207 and 24,046,806 shares issued, 24,802,296 and 22,447,895 shares outstanding, respectively 264 240
Additional paid-in capital 84,641 82,911
Accumulated deficit (74,433) (69,927)
Accumulated other comprehensive income 66 6
Treasury stock at cost, 1,598,911 shares (2,999) (2,999)
Total stockholders' equity 7,539 10,231
Total liabilities and stockholders' equity $ 24,048 $ 26,496
v3.23.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 2,000,000 2,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 60,000,000 60,000,000
Common stock, shares issued (in shares) 26,401,207 24,046,806
Common stock, shares outstanding (in shares) 24,802,296 22,447,895
Treasury stock at cost (in shares) 1,598,911 1,598,911
v3.23.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]        
Revenue $ 12,387 $ 12,745 $ 23,260 $ 25,020
Cost of revenue 9,172 9,573 17,650 19,421
Gross profit 3,215 3,172 5,610 5,599
Operating expenses:        
Selling, general and administrative 3,653 4,410 8,441 8,917
Research and development 154 182 335 324
Depreciation 53 72 101 144
Amortization of intangible assets 131 231 292 491
Total operating expenses 3,991 4,895 9,169 9,876
Operating loss (776) (1,723) (3,559) (4,277)
Other income and (expenses), net        
Interest expense, net (767) (358) (1,053) (506)
Change in fair value of derivative instruments, net 171 695 240 114
Other loss, net (98) (72) (88) (56)
Loss before income taxes (1,470) (1,458) (4,460) (4,725)
Provision for (benefit from) income taxes 28 (57) (11) 110
Net loss $ (1,498) $ (1,401) $ (4,449) $ (4,835)
Net loss per common share - basic (in dollars per share) $ (0.06) $ (0.07) $ (0.19) $ (0.23)
Net loss per common share - diluted (in dollars per share) $ (0.06) $ (0.07) $ (0.19) $ (0.23)
Weighted average shares outstanding used to compute net loss per share - basic (in shares) 24,188,265 21,033,447 23,564,133 21,006,910
Weighted average shares outstanding used to compute net loss per share - diluted (in shares) 24,188,265 21,033,447 23,564,133 21,006,910
v3.23.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]        
Net loss $ (1,498) $ (1,401) $ (4,449) $ (4,835)
Cumulative translation adjustment 70 (106) 60 75
Comprehensive loss $ (1,428) $ (1,507) $ (4,389) $ (4,760)
v3.23.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Loss [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Balance at Dec. 31, 2021 $ 225     $ 80,505     $ (54,584)     $ (104)     $ (2,999)     $ 23,043    
Balance (in shares) at Dec. 31, 2021 22,533,000                                  
Balance (in shares) at Dec. 31, 2021                         (1,599,000)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Stock-based compensation expense $ 0     1,025     0     0     $ 0     1,025    
Common stock issued for RSUs vested $ 3     (3)     0     0     0     0    
Common stock issued for RSUs vested (in shares) 317,000                                  
Shares withheld to pay taxes $ 0     (203)     0     0     0     (203)    
Foreign currency translation adjustment 0     0     0     75     0     75    
Net (loss) income 0     0     (4,835)     0     0     (4,835)    
Balance at Jun. 30, 2022 $ 228     81,324     (59,419)     (29)     $ (2,999)     19,105    
Balance (in shares) at Jun. 30, 2022 22,850,000                                  
Balance (in shares) at Jun. 30, 2022                         (1,599,000)          
Balance at Dec. 31, 2021 $ 225     80,505     (54,584)     (104)     $ (2,999)     23,043    
Balance (in shares) at Dec. 31, 2021 22,533,000                                  
Balance (in shares) at Dec. 31, 2021                         (1,599,000)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accounting Standards Update [Extensible Enumeration]               ASC 326 [Member] ASC 326 [Member]                  
Balance at Dec. 31, 2022 $ 240 $ 0 $ 240 82,911 $ 0 $ 82,911 (69,927) $ (57) $ (69,984) 6 $ 0 $ 6 $ (2,999) $ 0 $ (2,999) $ 10,231 $ (57) $ 10,174
Balance (in shares) at Dec. 31, 2022 24,047,000 0 24,047,000                         24,046,806    
Balance (in shares) at Dec. 31, 2022                         (1,599,000) 0 (1,599,000) (1,598,911)    
Balance at Mar. 31, 2022 $ 226     80,777     (58,018)     77     $ (2,999)     $ 20,063    
Balance (in shares) at Mar. 31, 2022 22,609,000                                  
Balance (in shares) at Mar. 31, 2022                         (1,599,000)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Stock-based compensation expense $ 0     666     0     0     $ 0     666    
Common stock issued for RSUs vested $ 2     (2)     0     0     0     0    
Common stock issued for RSUs vested (in shares) 241,000                                  
Shares withheld to pay taxes $ 0     (117)     0     0     0     (117)    
Foreign currency translation adjustment 0     0     0     (106)     0     (106)    
Net (loss) income 0     0     (1,401)     0     0     (1,401)    
Balance at Jun. 30, 2022 $ 228     81,324     (59,419)     (29)     $ (2,999)     19,105    
Balance (in shares) at Jun. 30, 2022 22,850,000                                  
Balance (in shares) at Jun. 30, 2022                         (1,599,000)          
Balance at Dec. 31, 2022 $ 240 $ 0 $ 240 82,911 $ 0 $ 82,911 (69,927) $ (57) $ (69,984) 6 $ 0 $ 6 $ (2,999) $ 0 $ (2,999) $ 10,231 $ (57) $ 10,174
Balance (in shares) at Dec. 31, 2022 24,047,000 0 24,047,000                         24,046,806    
Balance (in shares) at Dec. 31, 2022                         (1,599,000) 0 (1,599,000) (1,598,911)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Stock-based compensation expense $ 0     537     0     0     $ 0     $ 537    
Common stock issued for RSUs vested $ 4     (4)     0     0     0     0    
Common stock issued for RSUs vested (in shares) 380,000                                  
Shares withheld to pay taxes $ 0     (77)     0     0     0     (77)    
Foreign currency translation adjustment 0     0     0     60     0     60    
Repayment of convertible note in shares $ 20     1,274     0     0     0     1,294    
Repayment of convertible note in shares (in shares) 1,974,000                                  
Net (loss) income $ 0     0     (4,449)     0     0     (4,449)    
Balance at Jun. 30, 2023 $ 264     84,641     (74,433)     66     $ (2,999)     $ 7,539    
Balance (in shares) at Jun. 30, 2023 26,401,000                             26,401,207    
Balance (in shares) at Jun. 30, 2023                         (1,599,000)     (1,598,911)    
Balance at Mar. 31, 2023 $ 252     83,860     (72,935)     (4)     $ (2,999)     $ 8,174    
Balance (in shares) at Mar. 31, 2023 25,160,000                                  
Balance (in shares) at Mar. 31, 2023                         (1,599,000)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Stock-based compensation expense $ 0     263     0     0     $ 0     263    
Common stock issued for RSUs vested $ 2     (2)     0     0     0     0    
Common stock issued for RSUs vested (in shares) 259,000                                  
Shares withheld to pay taxes $ 0     (19)     0     0     0     (19)    
Foreign currency translation adjustment 0     0     0     70     0     70    
Repayment of convertible note in shares $ 10     539     0     0     0     549    
Repayment of convertible note in shares (in shares) 982,000                                  
Net (loss) income $ 0     0     (1,498)     0     0     (1,498)    
Balance at Jun. 30, 2023 $ 264     $ 84,641     $ (74,433)     $ 66     $ (2,999)     $ 7,539    
Balance (in shares) at Jun. 30, 2023 26,401,000                             26,401,207    
Balance (in shares) at Jun. 30, 2023                         (1,599,000)     (1,598,911)    
v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:        
Net loss $ (1,498) $ (1,401) $ (4,449) $ (4,835)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:        
Depreciation 53 72 101 144
Amortization of intangible assets 131 231 292 491
Amortization of capitalized software development costs     167 167
Amortization of deferred financing costs     15 7
Amortization of debt discount     556 482
Loss on debt settled in shares     145 0
Stock-based compensation expense     531 1,101
Credit loss expense (2) 97 30 97
Change in fair value of derivative instruments, net     (240) (114)
Foreign currency transaction (gain) loss     135 187
Deferred income taxes     6 77
Changes in assets and liabilities:        
Contract receivables, net     (254) 1,578
Prepaid expenses and other assets     1,472 3,020
Accounts payable, accrued compensation and accrued expenses     1,724 379
Billings in excess of revenue earned     (992) (588)
Accrued warranty     (72) (138)
Other liabilities     10 (416)
Net cash (used in) provided by operating activities     (823) 1,639
Cash flows from investing activities:        
Capital expenditures     (13) (134)
Capitalized software development costs     (239) (206)
Net cash used in investing activities     (252) (340)
Cash flows from financing activities:        
Repayment of line of credit     0 (1,817)
Repayment of insurance premium financing     (486) (594)
Proceeds from issuance of long-term debt and warrants     1,800 5,750
Payments of debt issuance and original discount on issuance of long-term debt and warrants     (386) (968)
Principal repayment of convertible note     (768) 0
Tax paid for shares withheld     (77) (203)
Net cash provided by financing activities     83 2,168
Effect of exchange rate changes on cash     (29) (70)
Net (decrease) increase in cash, cash equivalents and restricted cash     (1,021) 3,397
Cash, cash equivalents and restricted cash at beginning of the period     4,376 3,550
Cash, cash equivalents and restricted cash at the end of the period 3,355 6,947 3,355 6,947
Cash and cash equivalents 1,775 5,364 1,775 5,364
Restricted cash, current 500 632 500 632
Restricted cash included in other long-term assets 1,080 951 1,080 951
Total cash, cash equivalents and restricted cash 3,355 6,947 3,355 6,947
Non-cash financing activities        
Repayment of convertible note in shares     1,293 0
Establishment of new right-of-use assets     1,294 0
Establishment of new operating lease liability     (333) 0
Discount on issuance of convertible note $ 300 $ 750 $ 300 $ 750
v3.23.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 1 - Summary of Significant Accounting Policies

Basis of Presentation

GSE Systems, Inc. is a leading provider of professional and technical engineering, staffing services and simulation software to clients in the power and process industries. References in this report to “GSE” or “we” or “our” or “the Company” are to GSE Systems, Inc. and our subsidiaries, collectively.

The consolidated interim financial statements included herein have been prepared by GSE and are unaudited. In the opinion of our management, all adjustments and reclassifications of a normal and recurring nature necessary to present fairly the financial position, results of operations and cash flows for the periods presented, have been made. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted. All intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. The accompanying balance sheet data for the year ended December 31, 2022 was derived from our audited financial statements, but it does not include all disclosures required by U.S. GAAP.

The results of operations for interim periods are not necessarily an indication of the results for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission on April 17, 2023.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as reported amounts of revenues and expenses during the reporting period. Our most significant estimates relate to revenue recognition on contracts with customers, product warranties, valuation of goodwill and intangible assets acquired including the determination of fair value in impairment tests, valuation of long-lived assets to be disposed of, valuation of stock-based compensation awards, the recoverability of deferred tax assets, and valuation of warrants and derivative liabilities related to our convertible notes. Actual results of these and other items not listed could differ from these estimates and those differences could be material.

Liquidity and Going Concern

The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with U.S. GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and satisfy its liabilities and commitments in the normal course of business. Pursuant to the requirements of the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, are only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management determined that the implemented plans to mitigate relevant conditions may not alleviate management’s concerns that raise substantial doubt about the Company’s ability to continue as a going concern within the twelve months ended August 17, 2024.

On November 4, 2022, the Company received a notification letter from NASDAQ related to NASDAQ Listing Rules informing us that the Company no longer meets the requirement to maintain a minimum bid price of $1.00 per share. The Company filed a Form 8-K on November 8, 2022, to disclose receipt of this letter. The Company had an initial 180-day period (or until May 3, 2023) to cure this deficiency by maintaining a closing bid price of $1 per share for at least 10 consecutive trading days, and if compliance was not achieved within the initial 180 calendar days we could petition NASDAQ for an additional period of 180 calendar days in which to increase the stock price. Anticipating that it would not regain compliance with the NASDAQ minimum closing bid price requirement by May 3, 2023, on April 19, 2023, the Company submitted a request for an additional 180-day period within which to regain compliance.  On May 4, 2023, the Company received a letter from NASDAQ advising that the 180-day extension – expiring on October 30, 2023 – had been granted due to the facts that the Company:

had met the market value of publicly held shares requirement for continuing listing,
had met all other listing requirements for NASDAQ (other than bid price requirement), and
had provided written notice to NASDAQ with a plan of how it intends to regain compliance with the bid price requirement during the second 180-day period.

The Company’s plan to regain compliance includes continuing to monitor the closing bid price of its Common Stock and, if appropriate, implementing available options including, but not limited to, undertaking a reverse stock split of its outstanding securities at a ratio within the range of one-for-five to one-to-ten, which will have the initial effect of multiplying the trading price of the Company’s Common Stock by the same ratio. Because such an action requires stockholder approval, the Company put the matter before its stockholders for approval at the 2023 annual meeting of stockholders, which was held on June 12, 2023. The Company’s stockholders approved the proposal and, unless the Company’s Common Stock maintains a closing bid price of $1 per share for at least 10 consecutive trading days, the Company intends to effect a reverse stock split of its outstanding Common Stock at a ratio within the range of one-for-five to one-to-ten prior to October 30, 2023. We believe that compliance with the NASDAQ minimum bid price listing requirement will be achieved before the expiration of the second 180-day period.

If compliance is not achieved prior to October 30, 2023, and consequently a delisting letter is issued, the Company may request a hearing before the NASDAQ Hearing Panel with regard to delisting, which may have the effect of staying the delisting and provide the Company with the opportunity to present its further plans to regain compliance. If the Company’s Common Stock ceases to be listed on NASDAQ, Lind Global Fund II LP (“Lind Global”), as the holder of that certain convertible promissory note in the amount of $5,750,000 (as amended, the “2022 Convertible Note”) and that certain convertible promissory note in the amount of $1,800,000 (the “2023 Convertible Note” and, together with the 2022 Convertible Note, the “Convertible Notes”) (see Note 10 for further details), may deliver a notice of event of default together with a demand for payment to the Company for payment in full. If such a demand is delivered, the Company shall, within ten business days, pay all of the outstanding principal amount or, at its election, Lind Global may elect to convert all or a portion of the outstanding principal amount and the conversion price shall be adjusted to the lower of the then-current conversion price and 80% of the average of the three lowest daily variable average weighted prices during the twenty trading days prior to delivery. Additionally, if we are unable to maintain our listing on NASDAQ, it will constitute an event of default under the Convertible Notes, which would trigger certain obligations under the Convertible Notes including, but not limited to, causing an amount equal to 120% of the outstanding principal amount of the Convertible Notes to immediately become due. Although there can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement within the time period(s) permitted by NASDAQ or maintain compliance with any of the other NASDAQ continued listing requirements, having obtained the required stockholder vote at our annual meeting, we believe we will be able to remediate the noncompliance.

The Company has incurred operating losses and has not demonstrated an ability to generate cash in excess of its operating expenses for a sustained period of time. During the year ended December 31, 2022, the Company generated a loss from operations of $14.4 million, which includes non-cash impairment charges of long-lived assets and goodwill from our Workforce Solutions segment totaling $7.5 million. During the six months ended June 30, 2023, the Company generated a $0.8 million loss on net cash used in operating activities. As of June 30, 2023, the Company had domestic unrestricted cash and cash equivalents of $1.8 million which is not sufficient to fund the Company’s planned operations through one year after the date the consolidated financial statements are issued. These factors create substantial doubt about the Company’s ability to continue as a going concern for at least one year after the date that our audited consolidated financial statements are issued.

In making this assessment we performed a comprehensive analysis of our current circumstances and to alleviate these conditions, management is monitoring the Company’s performance and evaluating strategies to obtain the required additional funding for future operations. These strategies may include, but are not limited to, restructuring of operations to grow revenues and decrease expenses, obtaining equity financing, issuing debt, or entering into other financing arrangements. The analysis used to determine the Company’s ability to continue as a going concern does not include cash sources outside the Company’s direct control that management expects to be available within the next twelve months.
v3.23.2
Recent Accounting Pronouncements
6 Months Ended
Jun. 30, 2023
Recent Accounting Pronouncements [Abstract]  
Recent Accounting Pronouncements

Note 2 - Recent Accounting Pronouncements



Accounting pronouncements recently adopted



In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326) to replace the incurred loss impairment methodology under U.S. GAAP. This ASU introduces a new accounting model, the Current Expected Credit Losses model (CECL), which could result in earlier recognition of credit losses and additional disclosures related to credit risk. The CECL model will require the Company to use a forward-looking expected credit loss impairment methodology for the recognition of credit losses for financial instruments at the time the financial asset is originated or acquired, and require a loss be incurred before it is recognized. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. The new standard will apply to accounts receivable, loans, and other financial instruments. This standard is effective for the Company beginning January 1, 2023. The Company adopted the new guidance starting January 1, 2023 on a modified retrospective basis. The impact of this ASU is reflected in the consolidated financial statements and was not material.



Management has evaluated other recently issued accounting pronouncements and does not believe that any of these pronouncements will have a significant impact on our consolidated financial statements and related disclosures.
v3.23.2
Basic and Diluted Loss per Share
6 Months Ended
Jun. 30, 2023
Basic and Diluted Loss per Share [Abstract]  
Basic and Diluted Loss per Share
Note 3 - Basic and Diluted Loss per Share

Basic earnings per share is based on the weighted average number of outstanding common shares for the period. Diluted earnings per share adjusts the weighted average shares outstanding for the potential dilution that could occur if outstanding RSU’s, stock options and warrants were exercised. Basic and diluted earnings per share are based on the weighted average number of outstanding shares for the period.

The number of common shares and common share equivalents used in the determination of basic and diluted loss per common share were as follows:

(in thousands, except for share data)
 
Three months ended
   
Six months ended
 
   
June 30, 2023
   
June 30, 2022
   
June 30, 2023
   
June 30, 2022
 
Numerator:
                       
     Net loss attributed to common stockholders
 
$
(1,498
)
 
$
(1,401
)
 
$
(4,449
)
 
$
(4,835
)
                                 
Denominator:
                               
Weighted-average shares outstanding for basic earnings per share
   
24,188,265
     
21,033,447
     
23,564,133
     
21,006,910
 
                                 
Adjusted weighted-average shares outstanding and assumed conversions for diluted earnings per share
   
24,188,265
     
21,033,447
     
23,564,133
     
21,006,910
 
                                 
Total shares considered for dilution
   
11,769,795
     
5,352,245
     
12,263,781
     
5,352,245
 
v3.23.2
Coronavirus Aid, Relief and Economic Security Act
6 Months Ended
Jun. 30, 2023
Coronavirus Aid, Relief and Economic Security Act [Abstract]  
Coronavirus Aid, Relief and Economic Security Act
Note 4 - Coronavirus Aid, Relief and Economic Security Act

Employee Retention Credits (ERC)

Employee retention tax credits, made available under the CARES Act, allow eligible employers to claim a refundable tax credit against the employer share of Social Security tax equal to 70% of the qualified wages they pay to employees, initially from March 27, 2020 until June 30, 2021, and extended through September 30, 2021. In 2021, we applied for $5.0 million in refunds from the Internal Revenue Service with filing of our 941s and achieved $2.2 million in credits from unremitted payroll taxes as allowed. We recorded other income of $7.2 million related to the employee retention tax credits earned for the year ended December 31, 2021. During the three months ended June 30, 2023, we received $0.1 million refund, closing out our Employee tax refund credits totaling $5.0 million.
v3.23.2
Contract Receivables
6 Months Ended
Jun. 30, 2023
Contract Receivables [Abstract]  
Contract Receivables
Note 5 - Contract Receivables

Contract receivables represent our unconditional rights to consideration due from our domestic and international customers. We expect to collect all contract receivables within the next twelve months.

The components of contract receivables were as follows:

(in thousands)
 
June 30, 2023
   
December 31, 2022
 
             
Billed receivables
 
$
4,059
   
$
6,074
 
Unbilled receivables
   
6,590
     
5,146
 
Allowance for credit loss
   
(459
)
   
(1,156
)
Total contract receivables, net
 
$
10,190
   
$
10,064
 

During the first quarter of 2023, the Company adopted ASU 2016-13, “Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments.” This ASU replaces the incurred loss impairment model with an expected credit loss impairment model for financial instruments, including accounts receivable. Under the new guidance, an entity recognizes its estimate of lifetime expected credit losses as an allowance, which the FASB believes will result in more timely recognition of such losses. Under the CECL impairment model, the Company develops and documents its allowance for credit losses on its contract receivables based on three portfolio segments by customer geographic location:  North America, China, Rest of World (ROW). The determination of portfolio segments is based primarily on the qualitative consideration of the nature of the Company’s business operations and the characteristics of the underlying trade receivables.


The following table sets forth the activity in the allowance for credit losses for the three months ended June 30, 2023.


(in thousands)
     
Beginning balance at January 1, 2023
 
$
1,156
 
Adoption of ASC326 Current Expected Credit Losses (CECL)
    57  
Adjusted balance at January 1, 2023
    1,213  
Current period provision for expected credit loss
   
7
 
Write-offs charged against the allowance, net of recoveries
   
(722
)
Currency adjustment
    (39 )
Balance at June 30, 2023
 
$
459
 

During the three months ended June 30, 2023 and 2022, we recorded credit (recovery) loss expense of $(2) thousand and $97 thousand, respectively. During the six months ended June 30, 2023 and 2022, we recorded credit loss expense of $30 thousand and  $97 thousand, respectively. The write-offs charged against the allowance, net of recoveries is related to a  an unbilled receivable balance for a customer contract with our GSE Beijing entity, and had been fully reserved during the year ended 2021. During the three and six months ended June 30, 2023, management determine this amount to be fully uncollectible and has been written off  against the allowance.

During the month of July 2023, we invoiced $3.8 million of the unbilled receivables as of June 30, 2023.

Our foreign currency denominated contract receivables, billings in excess of revenue earned and subcontractor accruals that are related to the outstanding foreign exchange contracts are remeasured at the end of each reporting period into our functional currency, using the current exchange rate at the end of the period. The gain or loss resulting from such remeasurement is included in other income, net in the consolidated statements of operations. During the three months ended June 30, 2023 and 2022, we recognized a (loss) gain on remeasurement of these foreign exchange contracts of ($55) thousand and $51 thousand, respectively. During the six months ended June 30, 2023 and 2022, we recognized a gain on remeasurement of these foreign exchange contracts of $17 thousand and $54 thousand, respectively.
v3.23.2
Goodwill and Intangible Assets
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets [Abstract]  
Goodwill and Intangible Assets
Note 6 - Goodwill and Intangible Assets

The Company monitors operating results and events and circumstances that may indicate potential impairment of intangible assets. Management concluded that no triggering events that occurred during the six months ended June 30, 2023 and 2022.

During the three months ended September 30, 2022, we determined that the deterioration in sales, decline in revenues, delayed pipeline opportunities, and overall downward performance results and the forecast related to the Workforce Solutions business segment was material enough to be considered a triggering event that could result in impairment of our long-lived assets. We performed an interim analysis and determined an impairment existed at September 30, 2022 in accordance with ASC 350 & ASC 360. As such, we recorded an impairment of the related goodwill and definite-lived intangible assets of $7.0 million and $0.5 million, for the three months ended September 30, 2022, respectively.

Goodwill

The following table shows the gross carrying amount and impairment of goodwill:

(in thousands)

 
 
Goodwill
   
Accumulated
Impairment
   
Net
 

                 
Engineering
 
$
8,278
   
$
(3,370
)
 
$
4,908
 
Workforce Solutions
   
8,431
     
(7,040
)
   
1,391
 
Net book value at June 30, 2023
 
$
16,709
   
$
(10,410
)
 
$
6,299
 

(in thousands)

 
 
Goodwill
   
Accumulated
Impairment
   
Net
 

                 
Engineering
 
$
8,278
   
$
(3,370
)
 
$
4,908
 
Workforce Solutions
   
8,431
     
(7,040
)
   
1,391
 
Net book value at December 31, 2022
 
$
16,709
   
$
(10,410
)
 
$
6,299
 

Intangible assets

The following table shows the gross carrying amount and accumulated amortization of definite-lived intangible assets:

(in thousands)
 
As of June 30, 2023
 
   
Gross Carrying
Amount
   
Accumulated
Amortization
    Impairment    
Net
 
Amortized intangible assets:
                       
Customer relationships
 
$
8,628
   
$
(7,242
)
  $ (464 )  
$
922
 
Trade names
   
1,689
     
(1,239
)
    -      
450
 
Developed technology
   
471
     
(471
)
    -      
-
 
Non-contractual customer relationships
   
433
     
(433
)
    -      
-
 
Noncompete agreement
   
527
     
(504
)
    -      
23
 
Alliance agreement
   
527
     
(527
)
    -      
-
 
Others
   
167
     
(167
)
    -      
-
 
Total
 
$
12,442
   
$
(10,583
)
  $ (464 )  
$
1,395
 

(in thousands)
 
As of December 31, 2022
 
   
Gross Carrying
Amount
   
Accumulated Amortization
   
Impairment
   
Net
 
Amortized intangible assets:
                       
Customer relationships
 
$
8,628
   
$
(7,050
)
 
$
(464
)
 
$
1,114
 
Trade names
   
1,689
     
(1,196
)
   
-
     
493
 
Developed technology
   
471
     
(471
)
   
-
     
-
 
Non-contractual customer relationships
   
433
     
(433
)
   
-
     
-
 
Noncompete agreement
   
527
     
(486
)
   
-
     
41
 
Alliance agreement
   
527
     
(488
)
   
-
     
39
 
Others
   
167
     
(167
)
   
-
     
-
 
Total
 
$
12,442
   
$
(10,291
)
 
$
(464
)
 
$
1,687
 

Amortization expense related to definite-lived intangible assets totaled $0.1 million and $0.2 million for the three months ended June 30, 2023 and 2022 and $0.3 million and $0.5 million for the six months ended June 30, 2023 and 2022, respectively. The following table shows the estimated amortization expense of the definite-lived intangible assets for the next five years and thereafter:
 
(in thousands)
     
Years ended December 31:
     
2023 remainder
 
$
215
 
2024
   
332
 
2025
   
255
 
2026
   
204
 
2027
   
169
 
Thereafter
   
220
 
Total
 
$
1,395
 
v3.23.2
Equipment, Software and Leasehold Improvements
6 Months Ended
Jun. 30, 2023
Equipment, Software and Leasehold Improvements [Abstract]  
Equipment, Software and Leasehold Improvements
Note 7 - Equipment, Software and Leasehold Improvements

Equipment, software and leasehold improvements, net consist of the following:

(in thousands)
           
   
June 30, 2023
   
December 31, 2022
 
Computer and equipment
 
$
2,372
   
$
2,363
 
Software
   
2,291
     
2,291
 
Leasehold improvements
   
659
     
659
 
Furniture and fixtures
   
839
     
838
 
     
6,161
     
6,151
 
Accumulated depreciation
   
(5,479
)
   
(5,379
)
Equipment, software and leasehold improvements, net
 
$
682
   
$
772
 

Depreciation expense was $53 thousand and $72 thousand for the three months ended June 30, 2023 and 2022, respectively. Depreciation expense was $101 thousand and $144 thousand for the six months ended June 30, 2023 and 2022, respectively.
v3.23.2
Fair Value of Financial Instruments
6 Months Ended
Jun. 30, 2023
Fair Value of Financial Instruments [Abstract]  
Fair Value of Financial Instruments
Note 8 - Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The levels of the fair value hierarchy established by ASC 820 are:

Level 1:  inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2:  inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3:  inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

As of June 30, 2023 and December 31, 2022, we considered the recorded value of certain of our financial assets and liabilities, which consist primarily of cash and cash equivalents, contract receivable and accounts payable, to approximate fair value based upon their short-term nature.

Our convertible debt issued in February 2022, amended in June 2023 and our new convertible debt issued in June 2023 (see Note 10) includes certain embedded redemption features that are required to be bifurcated as embedded derivatives and measured at fair value on a recurring basis. We estimate the fair value using a Monte Carlo simulation based on estimates of our future stock price and assumptions about the possible redemption scenarios.

The Company used the Monte Carlo simulation model to determine the fair value of the Warrants (see Note 10) and Cash-Settled PRSUs, which required the input of subjective assumptions. The fair value of the Warrants as of June 30, 2023 was estimated with the following assumptions.
 

 
Amended 2022
Convertible Note
   
2023 Convertible
Note
 

           
Exercise Price
  $ 1.94     $ 0.50  
Common Stock Price
  $ 0.36    
$
0.36
 
Risk Free Rate
    4.31%

    4.13%

Volatility
    70.0%

    75.0%

Term (in years)
  3.7 yrs.     2.0 yrs.
 

The following table presents assets and liabilities measured at fair value at June 30, 2023:

(in thousands)
 
Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
   
Significant
Other Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Total
 
                         
Derivative liability   $ -     $ -     $ 664     $ 664  
Warrant liability
    -       -       1,054       1,054  
Cash settled performance-vesting restricted stock units
    -       -       89       89  
 Total liabilities   $ -     $ -     $ 1,807     $ 1,807  

The following table presents assets and liabilities measured at fair value at December 31, 2022:

(in thousands)
 
Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
   
Significant
Other Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Total
 
                         
Derivative liability   $ -     $ -     $ 285     $ 285  
Warrant liability
    -       -       267       267  
Cash settled performance-vesting restricted stock units
    -       -       51       51  
 Total liabilities   $ -     $ -     $ 603     $ 603  

The following table summarizes changes in the fair value of our Level 3 liabilities during the six months ended June 30, 2023.

(in thousands)
 
Embedded
Redemption
Features
    Warrant    
Cash Settled
PRSUs
    Level 3 Total
 
Balance at December 31, 2022
 
$
285
    $ 267     $ 51     $ 603  
FV of derivatives with new convertible note issuance
    286       1,120       -       1,406  
Change in FV included in gain on derivative instruments, net
    93       (333 )     -       (240 )
Stock compensation less payments made
    -
      -
      38
      38
 
Balance at June 30, 2023
 
$
664
    $ 1,054     $ 89     $ 1,807  
v3.23.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2023
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
Note 9 - Stock-Based Compensation

We recognize compensation expense on a pro rata straight-line basis over the requisite service period for stock-based compensation awards with both graded and cliff vesting terms. We recognize the cumulative effect of a change in the number of awards expected to vest in compensation expense in the period of change. We have not capitalized any portion of our stock-based compensation. Our forfeiture rate is based on actuals.


During the three months ended June 30, 2023 and 2022, we recognized $0.3 million and $0.7 million of stock-based compensation expense related to equity awards, respectively, under the fair value method. We recognized $0.5 million and $1.0 million of stock-based compensation expense related to equity awards for the six months ended June 30, 2023 and 2022, respectively.



During the three and six months ended June 30, 2023, we granted approximately 408,270 and 453,270 time-based restricted stock units (“RSUs”) with an aggregate fair value of approximately $0.2 million and $0.2 million, respectively. During the three and six months ended June 30, 2022, we granted approximately 946,653  and 960,250 time-based RSUs with an aggregate fair value of approximately $1.4 million and $1.5 million, respectively. During the three months ended June 30, 2023 and 2022, we vested approximately 269,000 and 258,000 RSUs, respectively During the six months ended June 30, 2023 and 2022, we vested approximately 434,000 and 380,000 RSUs, respectively. A portion of the time-based RSUs vest quarterly in equal amounts over the course of eight quarters, and the remainder vest annually in equal amounts over the course of one to three years.

GSE’s 1995 long-term incentive program (“LTIP”) provides for the issuance of performance-vesting and time-vesting RSUs to certain executives and employees. Vesting of the performance-vesting restricted stock units (“PRSU”) is contingent upon the employee’s continued employment and the Company’s achievement of certain performance goals during designated performance periods as established by the Compensation Committee of the Company’s Board of Directors. We recognize compensation expense, net of estimated forfeitures, for PRSUs on a straight-line basis over the performance period based on the probable outcome of achievement of the financial targets. At the end of each reporting period, we estimate the number of PRSUs that are expected to vest, based on the probability and extent to which the performance goals will be met, and take into account these estimates when calculating the expense for the period. If the number of shares expected to be earned changes during the performance period, we make a cumulative adjustment to compensation expense based on the revised number of shares expected to be earned.

During the three and six months ended June 30, 2023, we granted approximately 597,665 PRSU’s. These grants are subject to multiple vesting criteria including reaching a 20-day VWAP of $1.50 prior to the expiration of the awards, and a time-vesting restriction, which will vest in equal parts over the next 18 quarters. During the three months ended June 30, 2022, there were no PRSUs granted compared to 800,000 during the six months ended June 30, 2022, including 200,000 cash-settled grants to employees. These grants are subject to multiple vesting criteria including reaching a 20-day VWAP of $1.94 prior to the expiration of the awards, and a time-vesting restriction, which will vest in equal portions over the next 15 quarters ending December 31, 2025. During the six months ended June 30, 2023 and 2022, we vested 100,000 PRSUs, of which, 25,000 PRSUs were cash-settled, respectively. The market vesting criteria for the Q1 2022 PRSU grant was achieved in April 2022 for the 800,000 PRSUs which will fully vest over the next 10 quarters.

We did not grant any stock options for the six months ended June 30, 2023 and 2022.
v3.23.2
Debt
6 Months Ended
Jun. 30, 2023
Debt [Abstract]  
Debt
Note 10 - Debt

Convertible Note

On February 23, 2022, we entered into a Securities Purchase Agreement, as amended, with Lind Global, pursuant to which we issued to Lind Global the 2022 Convertible Note (see Note 1) and a common stock purchase warrant to acquire 1,283,732 shares of our Common Stock (the “2022 Warrant”). The 2022 Convertible Note does not bear interest but was issued at a $0.75 million discount (“OID”). We received proceeds of approximately $4.8 million net of the OID and expenses.


On June 23, 2023, we entered into a Amended & Restated Agreement to amend the February 23, 2022 Securities Purchase Agreement (Original Note).

   
2022
Convertible
Note
   
2023
Convertible
Note
   
Total
Convertible
Notes
 
   
Amount
    Amount     Amount  
                   
Convertible Note issued
  $ 5,750       1,800
      7,550
 
Debt discount
    (750 )     (300 )     (1,050 )
Issuance cost:
                       
Commitment fee
    (175 )     (52 )     (227 )
Balance of investor’s counsel fees
    (43 )     (34 )     (77 )
Net proceeds of Convertible Note
  $ 4,782       1,414
      6,196
 

                       
Additional OID costs not in original funds flow     (121 )     (15 )     (136 )
Fair value of Warrant Liabilities on issuance
    (724 )     (1,119 )     (1,843 )
Fair value of Conversion Feature on issuance
    (306 )     (286 )     (592 )
Allocated OID costs to Warrants     25       30
      55
 
Additional OID costs not in original funds flow
    (660 )     660
      -
 
Interest expense accrued on Convertible Note as of June 30, 2023
    2,346       9
      2,355
 
Principal and interest payments through June 30, 2023     (3,514 )     -
      (3,514 )
     
                 
Balance of Convertible Note as of June 30, 2023   $ 1,828       693       2,521  

The Convertible Note provides for 18 monthly principal repayments of $319 thousand beginning 180 days from issuance.  Payments could be made in the form of cash, shares, or a combination of both at the discretion of GSE.

The 2022 Convertible Note is convertible into our Common Stock at any time after the earlier of six months from issuance of the Convertible Note or the date of an effective registration statement filed with the SEC covering the underlying shares. The conversion price of the 2022 Convertible Note is equal to $1.94 per share, subject to customary adjustments. The 2022 Convertible Note matures in February of 2024, although we are permitted to prepay the 2022 Convertible Note, provided that Lind Global shall have the option to convert up to one third of the outstanding principal of the 2022 Convertible Note at a price per share equal to the lessor of the Repayment Share price or the conversion price (as described below). The 2022 Convertible Note is guaranteed by each of our subsidiaries and is secured by a first priority lien on all of our assets. The 2022 Convertible Note is not subject to any financial covenants and events of default under the 2022 Convertible Note are limited to events related to payment, market capitalization, certain events pertaining to conversion and the underlying shares of Common Stock and other customary events including, but not limited to, bankruptcy or insolvency. Upon the occurrence of an event of default, the 2022 Convertible Note will become immediately due and payable at an amount equal to 120% of the outstanding principal, subject to any cure periods described in the 2022 Convertible Note, and the customer may demand that all or a portion of the outstanding principal amount be converted into shares of common stock at the lower of the then current conversion price and 80% of the average of the three lowest daily volume-weighted average price (“VWAPs”) during the twenty days prior to delivery of the conversion notice. If there is a change of control of the Company, Lind Global has the right to require us to prepay the outstanding principal amount of the 2022 Convertible Note.

On June 23, 2023, the Company and Lind Global agreed to amend and restate the 2022 Convertible Note. The 2022 Convertible Note, as now amended, is now secured, interest free convertible promissory note in the principal amount of $2,747,228, such amount being the outstanding balance of the 2022 Convertible Note as of June 23, 2023. Just prior to the amendment, there was an event of default (EOD) related to the total market capitalization provision in the original 2022 Convertible Note. The EOD that occurred was waived, and we incurred a 20% charge included in the amended and restated 2022 Convertible Note, which the Company has treated as additional interest. The 2022 Convertible Note now has a maturity date of August 23, 2024 and is now payable, commencing on July 23, 2023, in twelve (12) consecutive monthly payments of $186,343 each and two (2) final payments of $255,556 each. The remainder of the terms of the 2022 Convertible Note, including terms around payment, prepayment, default and conversion, are unchanged.

The 2022 Warrant entitles Lind Global to purchase up to 1,283,732 shares of our Common Stock until February 23, 2027, at an exercise price of $1.94 per share, subject to customary adjustments described therein.  The Warrant is recorded at fair value upon issuance of $0.7 million and is classified as a current liability to be remeasured at each reporting period (see Note 8). The discount created by allocating proceeds to the Warrant results in a debt discount to be amortized as additional interest expense over the term of the Convertible Note.

On June 23, 2023 in connection with the 2022 amended and restated Convertible Note transaction, the Company evaluated the amendment and concluded it qualified as a troubled debt restructuring.  The restructuring did not result in a gain or loss but revised the effective interest rate used to amortized the note going forward.


On June 23, 2023, the Company entered into a second Securities Purchase Agreement (the “2023 Purchase Agreement”) with Lind Global, pursuant to which the Company issued to Lind Global the 2023 Convertible Note.  The Company and Lind Global also amended and restated the 2022 Convertible Note.  The closings of the transactions contemplated under the 2023 Purchase Agreement may occur in tranches.  The first closing occurred on June 23, 2023, and consisted of the issuance of a secured, two-year interest free convertible promissory note with a funding amount of $1,500,000 and a principal amount of $1,800,000 (the 2023 Convertible Note) and the issuance of common stock purchase warrant to acquire 4,264,271 shares of the Company’s common stock (the “2023 Warrant” and, together with the 2022 Warrant, the “Warrants”). The proceeds from the transactions contemplated by the 2023 Purchase Agreement were for general working capital purposes and other corporate purposes.


Commencing one year after the issuance of the 2023 Convertible Note, the Company shall pay the outstanding principal amount of the 2023 Convertible Note in twelve (12) consecutive monthly payments of $150,000 each. At the option of the Company, the monthly payment can be made in cash, shares of the common stock of the Company (the “Repayment Shares”) at a price based on 90% of the average five (5) consecutive daily VWAPs during the twenty (20) days prior to the payment date, or a combination of cash and Repayment Shares, subject to the terms of the 2023 Convertible Note.  The Repayment Shares must either be eligible for immediate resale under Rule 144 or be registered. The number of Repayment Shares is limited such that, when added to the number of shares of common stock issued and issuable pursuant to the transactions contemplated by the 2023 Purchase Agreement, it may not exceed 4,937,271 shares of common stock unless the Company obtains stockholder approval to issue additional Repayment Shares. The holder of the 2023 Convertible Note may elect with respect to no more than two (2) of the above described monthly payments to increase the amount of such monthly payment up to $300,000 each in Repayment Shares upon notice to the Company. Any such increased payment shall be deducted from the amount of the last monthly payment owed under the 2023 Convertible Note.  The Company can prepay Lind Global all the outstanding principal amount of the 2023 Convertible Note, provided that Lind Global shall have the option to convert up to one third (1/3) of the outstanding principal amount of the 2023 Convertible Note at a price per share equal to the lesser of the Repayment Share price or the conversion price (as described below).


Upon the occurrence of an event of default as described in the 2023 Convertible Note, the 2023 Convertible Note will become immediately due and payable at the default premium described in the 2023 Convertible Note, subject to any cure periods described in the 2023 Convertible Note. Events of default include, but are not limited to, a payment default on any other indebtedness in excess of $250,000; the shares no longer publicly being traded or cease to be listed on a trading market; if after six months, the shares are not available for immediate resale under Rule 144; and the Company’s market capitalization is below $7,000,000 for ten (10) consecutive days. Upon an event of default, subject to any applicable cure period, the holder of the 2023 Convertible Note can, among other things, accelerate payment of the 2023 Convertible Note and demand full payment and demand that all or a portion of the outstanding principal amount be converted into shares of common stock at the at the lower of the then current conversion price and 85% of the average of the three (3) lowest daily VWAPs during the twenty (20) days prior to delivery of the conversion notice.  If there is a change of control of the Company, Lind Global has the right to require the Company to prepay the outstanding principal amount of the 2023 Convertible Note. A change of control includes a change in the composition of a majority of the Board of Directors of the Company, at a single shareholder meeting, a change, without prior written consent of Lind Global where a majority of the individuals that were directors as of June 20, 2023 cease to be directors of the Company (provided that any individual who is nominated by the board of directors (or a duly authorized committee thereof) as of June 20, 2023 and is elected or appointed as a director of the Company shall be deemed a member of the board of directors of the Company for all such purposes), a shareholder acquiring beneficial ownership of more than 50% of the common stock of the Company, or the sale or other disposition of the Company of all or substantially all of its assets.  The 2023 Convertible Note is convertible into common stock of the Company at any time after the earlier of six (6) months from issuance or the date the registration statement is effective, provided that no such conversion may be made that would result in beneficial ownership by Lind Global and its affiliates of more than 4.99% of the Company’s outstanding shares of common stock. The conversion price of the 2023 Convertible Note is equal to $0.50, subject to customary adjustments.


The 2023 Warrant entitles Lind Global to purchase up to 4,264,271 shares of common stock of the Company until the earlier of (a) June 23, 2028 and (b) a merger, sale event or other reclassification of the Company’s common stock, at an exercise price of $0.50 per share, subject to customary adjustments described therein. The 2023 Warrant is in addition to the 2022 Warrant.

The Company evaluated the Convertible Notes and concluded that certain embedded redemption features are required to be accounted for as a derivative liability. Embedded redemption features were recorded at fair value upon issuance of $0.3 million and are classified as current liabilities to be remeasured at each reporting period (see Note 8). The discount created by allocating proceeds to the derivative liability results in a debt discount to be amortized as additional interest expense over the term of the Convertible Notes. The Warrants are accounted for as a derivative liability based on certain features included within the Convertible Note which caused the Company to not be able to assert that it would have sufficient shares in all cases to be able to settle the Warrants. As such, the proceeds (approximately $4.8 million, net of original issue discounts and other payments to lender) were allocated first to the fair value of the Warrants with the residual allocated to the Convertible Notes host instrument. The proceeds allocated to the Convertible Notes were further allocated first to the bifurcated derivative liability based on its fair value with the residual being allocated to the Convertible Notes host instrument.

Upon issuance of the 2023 Convertible Note, the Company re-evaluated the 2022 Convertible Note, in accordance with ASC 815-40-25-10 and its sequencing policy, and concluded that the embedded conversion option is required to be bifurcated and accounted for as a derivative liability as a result of the Company not being able to assert that it would have sufficient shares in all cases to be able to settle the conversion of the 2022 Convertible Note.  The embedded conversion option will be combined with the bifurcated redemption features as a single derivative and is classified as a current liability to be remeasured at each reporting period.  The discount resulting from bifurcating the embedded conversion option will be amortized as additional interest expense over the term of the 2022 Convertible Note.

The direct and incremental costs incurred are allocated to the Convertible Note and the Warrant based on a systematic and rational approach. The costs allocated to the Warrants have been expensed as incurred while those allocated to the Convertible Note have been capitalized and will be amortized as interest expense over the life of the Convertible Notes based on the effective interest rate. The Company will record ongoing changes to the fair value of the derivative liabilities as other non-operating income (expense).

The Convertible Notes were evaluated as a potentially dilutive security in both periods of loss and income for diluted earnings per share purposes. The Warrants are considered a participating security and was not included in the calculation of basic earnings per share for the period ended June 30, 2023 as Company reflected net loss for this period. The Warrant will be included in the calculation of basic earnings per share in periods of net income.

The issuance costs with respect to the Convertible Notes, which are recorded as a debt discount, are deferred and amortized using the effective interest method as additional interest expense over the terms of the Convertible Note at an effective interest rate of 68.6%.

The Company incurred total interest expense related to the Convertible Notes of $1.1 million, including $0.5 million default charge and the amortization of the various discounts for the six months ended June 30, 2023, respectively.

Revolving Line of Credit

In February 2022, using proceeds from the Convertible Note, we repaid in full, all outstanding indebtedness of $1.8 million owed to Citizens, and the Amended and Restated Credit and Security Agreement between us, our subsidiaries, and Citizens was terminated. Certain letters of credit remain in place with Citizens. As of June 30, 2023, we had four letters of credit totaling $1.1 million outstanding to certain customers which were secured with restricted cash.
v3.23.2
Product Warranty
6 Months Ended
Jun. 30, 2023
Product Warranty [Abstract]  
Product Warranty
Note 11 - Product Warranty

We accrue estimated warranty costs at the time the related revenue is recognized and based on historical experience and projected claims. Our System Design and Build contracts generally include a one year base warranty on the systems. The portion of our warranty provision expected to be incurred within twelve months is classified as current within accrued warranty and totals $276 thousand, and the remaining $151 thousand is classified as long-term within other non-current liabilities.

The activity in the accrued warranty accounts during the current period is as follows:

(in thousands)
     
Balance at January 1, 2023
 
$
503
 
Current period recovery